Integrilin in Acute Myocardial Infarction - INTAMI


The goal of the trial was to evaluate adjunctive therapy with the glycoprotein IIb/IIIa inhibitor eptifibatide administered early in the emergency department compared with late, optional administration in the catheterization laboratory among patients with acute ST elevation myocardial infarction (MI) undergoing primary percutaneous coronary intervention (PCI).